Nunes, Edward V.

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Lee, J. D., Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., Farkas, S., Fishman, M., Gauthier, P., Hodgkins, C. C., et al. (2018) · The Lancet

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 700

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

Krupitsky, E., Nunes, E. V., Ling, W., Illeperuma, A., Gastfriend, D. R., & Silverman, B. L. (2011) · The Lancet

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 555

Cognitive deficits predict low treatment retention in cocaine dependent patients

Aharonovich, E., Hasin, D. S., Brooks, A. C., Liu, X., Bisaga, A., & Nunes, E. V. (2006) · Drug and Alcohol Dependence

Substance Abuse Treatment and OutcomesHistorical and Modern Theater Studies

Cited by 397

Development of a Cascade of Care for responding to the opioid epidemic.

Williams, A. R., Nunes, E. V., Bisaga, A., Levin, F. R., & Olfson, M. (2019) · The American Journal of Drug and Alcohol Abuse

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 332

Extended-release naltrexone to prevent opioid relapse in criminal justice offenders

Lee, J. D., Friedmann, P. D., Kinlock, T. W., Nunes, E. V., Boney, T. Y., Hoskinson, R. A., Wilson, D., McDonald, R., Rotrosen, J., Gourevitch, M. N., et al. (2016) · New England Journal of Medicine

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 315

Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA’s Clinical Trials Network

Hien, D. A., Jiang, H., Campbell, A. N. C., Hu, M.-C., Miele, G. M., Cohen, L. R., Brigham, G. S., Capstick, C., Kulaga, A., Robinson, J., et al. (2010) · American Journal of Psychiatry

Posttraumatic Stress Disorder ResearchSubstance Abuse Treatment and Outcomes

Cited by 309

Bupropion and naltrexone in methamphetamine use disorder

Trivedi, M. H., Walker, R., Ling, W., dela Cruz, A., Sharma, G., Carmody, T., Ghitza, U. E., Wahle, A., Kim, M., Shores-Wilson, K., et al. (2021) · New England Journal of Medicine

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 281

Divalproex Treatment for Youth With Explosive Temper and Mood Lability: A Double-Blind, Placebo-Controlled Crossover Design

Donovan, S. J., Stewart, J. W., Nunes, E. V., Quitkin, F. M., Parides, M., Daniel, W., Susser, E., & Klein, D. F. (2000) · American Journal of Psychiatry

Child and Adolescent Psychosocial and Emotional DevelopmentAttention Deficit Hyperactivity Disorder

Cited by 273

Internet-delivered treatment for substance abuse: a multisite randomized controlled trial

Campbell, A. N. C., Nunes, E. V., Matthews, A. G., Stitzer, M., Miele, G. M., Polsky, D., Turrigiano, E., Walters, S., McClure, E. A., Kyle, T. L., et al. (2014) · American Journal of Psychiatry

Substance Abuse Treatment and OutcomesDigital Mental Health Interventions

Cited by 263

Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double‐blind randomized controlled trial

Zangen, A., Moshe, H., Martinez, D., Barnea‐Ygael, N., Vapnik, T., Bystritsky, A., Duffy, W., Toder, D., Casuto, L., Grosz, M. L., et al. (2021) · World Psychiatry

Transcranial Magnetic Stimulation StudiesSmoking Behavior and Cessation

Cited by 247

Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial.

Levin, F. R., Mariani, J. J., Brooks, D. J., Pavlicova, M., Cheng, W., & Nunes, E. V. (2011) · Drug and Alcohol Dependence

Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and Outcomes

Cited by 232

Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment

Martinez, D., Carpenter, K. M., Liu, F., Slifstein, M., Broft, A., Friedman, A. C., Kumar, D., Van Heertum, R., Kleber, H. D., & Nunes, E. (2011) · American Journal of Psychiatry

Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes

Cited by 212

A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial

Dakwar, E., Nunes, E. V., Hart, C. L., Foltin, R. W., Mathew, S. J., Carpenter, K. M., Choi, C. J. “., Basaraba, C. N., Pavlicova, M., & Levin, F. R. (2019) · American Journal of Psychiatry

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 186

A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial

Dakwar, E., Levin, F., Hart, C. L., Basaraba, C., Choi, J., Pavlicova, M., & Nunes, E. V. (2020) · American Journal of Psychiatry

Substance Abuse Treatment and OutcomesTreatment of Major Depression

Cited by 183

Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial

Levin, F. R., Mariani, J. J., Specker, S., Mooney, M., Mahony, A., Brooks, D. J., Babb, D., Bai, Y., Eberly, L. E., Nunes, E. V., et al. (2015) · JAMA Psychiatry

Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and Outcomes

Cited by 179

The Effects of Subanesthetic Ketamine Infusions on Motivation to Quit and Cue-Induced Craving in Cocaine-Dependent Research Volunteers

Dakwar, E., Levin, F., Foltin, R. W., Nunes, E. V., & Hart, C. L. (2014) · Biological Psychiatry

Substance Abuse Treatment and OutcomesTreatment of Major Depression

Cited by 143

Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders

Riggs, P. D., Winhusen, T., Davies, R. D., Leimberger, J. D., Mikulich-Gilbertson, S., Klein, C., Macdonald, M., Lohman, M., Bailey, G. L., Haynes, L., et al. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and Outcomes

Cited by 124

Therapeutic infusions of ketamine: do the psychoactive effects matter?

Dakwar, E., Anerella, C., Hart, C. L., Levin, F. R., Mathew, S. J., & Nunes, E. V. (2014) · Drug and Alcohol Dependence

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 123

Relapse to opioid use disorder after inpatient treatment: protective effect of injection naltrexone

Nunes, E. V., Gordon, M., Friedmann, P. D., Fishman, M. J., Lee, J. D., Chen, D. T., Hu, M. C., Boney, T. Y., Wilson, D., & O'Brien, C. P. (2018) · Journal of Substance Abuse Treatment

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 122

Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium.

Levin, F. R., McDowell, D., Evans, S. M., Nunes, E., Akerele, E., Donovan, S., & Vosburg, S. K. (2004) · The American Journal on Addictions

Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and Outcomes

Cited by 113

Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.

Levin, F. R., Mariani, J. J., Pavlicova, M., Brooks, D., Glass, A., Mahony, A., Nunes, E. V., Bisaga, A., Dakwar, E., Carpenter, K. M., et al. (2016) · Drug and Alcohol Dependence

Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and Outcomes

Cited by 109

Procedural validity of the AUDADIS-5 depression, anxiety and post-traumatic stress disorder modules: Substance abusers and others in the general population

Hasin, D. S., Shmulewitz, D., Stohl, M., Greenstein, E., Aivadyan, C., Morita, K., Saha, T., Aharonovich, E., Jung, J., Zhang, H., et al. (2015) · Drug and Alcohol Dependence

Substance Abuse Treatment and OutcomesAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 107

Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: a randomized, crossover trial

Dakwar, E., Hart, C. L., Levin, F. R., Nunes, E. V., & Foltin, R. W. (2017) · Molecular Psychiatry

Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes

Cited by 105

Bupropion Treatment for Cocaine Abuse and Adult Attention-Deficit/Hyperactivity Disorder

Levin, F. R., Evans, S. M., McDowell, D. M., Brooks, D. J., & Nunes, E. (2002) · Journal of Addictive Diseases

Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and Outcomes

Cited by 102